Your browser doesn't support javascript.
loading
Risk-reducing hysterectomy and bilateral salpingo-oophorectomy in female heterozygotes of pathogenic mismatch repair variants: a Prospective Lynch Syndrome Database report.
Dominguez-Valentin, Mev; Crosbie, Emma J; Engel, Christoph; Aretz, Stefan; Macrae, Finlay; Winship, Ingrid; Capella, Gabriel; Thomas, Huw; Nakken, Sigve; Hovig, Eivind; Nielsen, Maartje; Sijmons, Rolf H; Bertario, Lucio; Bonanni, Bernardo; Tibiletti, Maria Grazia; Cavestro, Giulia Martina; Mints, Miriam; Gluck, Nathan; Katz, Lior; Heinimann, Karl; Vaccaro, Carlos A; Green, Kate; Lalloo, Fiona; Hill, James; Schmiegel, Wolff; Vangala, Deepak; Perne, Claudia; Strauß, Hans-Georg; Tecklenburg, Johanna; Holinski-Feder, Elke; Steinke-Lange, Verena; Mecklin, Jukka-Pekka; Plazzer, John-Paul; Pineda, Marta; Navarro, Matilde; Vidal, Joan Brunet; Kariv, Revital; Rosner, Guy; Piñero, Tamara Alejandra; Gonzalez, María Laura; Kalfayan, Pablo; Ryan, Neil; Ten Broeke, Sanne W; Jenkins, Mark A; Sunde, Lone; Bernstein, Inge; Burn, John; Greenblatt, Marc; de Vos Tot Nederveen Cappel, Wouter H; Della Valle, Adriana.
Afiliação
  • Dominguez-Valentin M; Department of Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo, Norway. mev.dominguez.valentin@rr-research.no.
  • Crosbie EJ; Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester and St Mary's Hospital, Manchester, UK. Emma.Crosbie@manchester.ac.uk.
  • Engel C; Directorate of Gynaecology, Manchester University NHS Foundation Trust, Manchester, UK. Emma.Crosbie@manchester.ac.uk.
  • Aretz S; Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany.
  • Macrae F; Institute of Human Genetics, University of Bonn, Bonn, Germany.
  • Winship I; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
  • Capella G; Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Melbourne, Australia.
  • Thomas H; Department of Medicine, Melbourne University, Melbourne, Australia.
  • Nakken S; Colorectal Medicine and Genetics, The Royal Melbourne Hospital, Melbourne, Australia.
  • Hovig E; Department of Medicine, Melbourne University, Melbourne, Australia.
  • Nielsen M; Hereditary Cancer Program, Institut Catal. d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Sijmons RH; St Mark's Hospital, Department of Surgery and Cancer, Imperial College London, London, UK.
  • Bertario L; Department of Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo, Norway.
  • Bonanni B; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway.
  • Tibiletti MG; Department of Department of Tumor Biology, Institute of Cancer Research, The Norwegian Radium Hospital, Oslo, Norway.
  • Cavestro GM; Department of Informatics, University of Oslo, Oslo, Norway.
  • Mints M; Leids Universitair Medisch Centrum, Leiden, Netherlands.
  • Gluck N; Department of Genetics, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.
  • Katz L; IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Heinimann K; Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Vaccaro CA; IEO, European Institute of Oncology IRCCS, Milan, Italy.
  • Green K; Ospedale di Circolo ASST Settelaghi, Centro di Ricerca tumori eredo-familiari, Università dell'Insubria, Varese, Italy.
  • Lalloo F; Gastroenterology and Gastrointestinal Endoscopy Unit, Vita-Salute San Raffaele University, San Raffaele Scientific Institute, Milan, Italy.
  • Hill J; Department of Women's and Children's health, Division of Obstetrics and Gyneacology, Karolinska Institutet, Karolinska University Hospital, Solna, Stockholm, Sweden.
  • Schmiegel W; Tel-Aviv Sourasky Medical Center, Research Center for Digestive Disorders and Liver Diseases, Tel-Aviv, Israel.
  • Vangala D; Department of Gastroenterology, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Perne C; High Risk and GI Cancer prevention Clinic, Gastro-Oncology Unit, The Department of Gastroenterology, Sheba Medical Center, Tel-Aviv, Israel.
  • Strauß HG; Medical Genetics, Institute for Medical Genetics and Pathology, University Hospital Basel, Basel, Switzerland.
  • Tecklenburg J; Hereditary Cancer Program (PROCANHE) Hospital Italiano de Buenos Aires, Buenos Aires, Argentina.
  • Holinski-Feder E; Instituto de Ciencias Básicas y Medicina Experimental (ICBME)-Instituto Universitario (IU)-Hospital, Buenos Aires, Argentina.
  • Steinke-Lange V; Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
  • Mecklin JP; Manchester Centre for Genomic Medicine, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
  • Plazzer JP; Department of Surgery, Manchester University Hospitals NHS Foundation Trust and University of Manchester, Manchester, UK.
  • Pineda M; Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany.
  • Navarro M; Department of Medicine, Knappschaftskrankenhaus, Ruhr-University Bochum, Bochum, Germany.
  • Vidal JB; Institute of Human Genetics, University of Bonn, Bonn, Germany.
  • Kariv R; National Center for Hereditary Tumor Syndromes, University Hospital Bonn, Bonn, Germany.
  • Rosner G; Department of Gynaecology, University Clinics, Martin-Luther University, Halle-Wittenberg, Germany.
  • Piñero TA; Institute of Human Genetics, Hannover Medical School, Hannover, Germany.
  • Gonzalez ML; Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.
  • Kalfayan P; MGZ Medical Genetics Center, Munich, Germany.
  • Ryan N; Medizinische Klinik und Poliklinik IV, Campus Innenstadt, Klinikum der Universität München, Munich, Germany.
  • Ten Broeke SW; MGZ Medical Genetics Center, Munich, Germany.
  • Jenkins MA; Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland.
  • Sunde L; Department of Surgery, Central Finland Health Care District, Jyväskylä, Finland.
  • Bernstein I; The Royal Melbourne Hospital, Melbourne, Australia.
  • Burn J; Hereditary Cancer Program, Institut Català d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Greenblatt M; Hereditary Cancer Program, Institut Català d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • de Vos Tot Nederveen Cappel WH; Hereditary Cancer Program, Institut Català d'Oncologia-IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Della Valle A; Department of Gastroenterology, Tel-Aviv Sourasky Medical Center and Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
Genet Med ; 23(4): 705-712, 2021 04.
Article em En | MEDLINE | ID: mdl-33257847
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Hereditárias sem Polipose Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Noruega País de publicação: Estados Unidos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais Hereditárias sem Polipose Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Middle aged Idioma: En Revista: Genet Med Assunto da revista: GENETICA MEDICA Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Noruega País de publicação: Estados Unidos